What causes gbs bacteria

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 4, 2026

Quick Answer: Group B Strep (GBS) bacteria, also known as *Streptococcus agalactiae*, is a common bacterium that can live in the body, typically in the digestive tract or vagina, without causing harm to most healthy adults. However, it can pose serious health risks to newborns if transmitted during childbirth.

Key Facts

What is Group B Strep (GBS)?

Group B Strep (GBS), scientifically named *Streptococcus agalactiae*, is a type of bacterium that is commonly found in the human body. It is a part of the normal flora, meaning it can reside in certain areas of the body without causing illness in most healthy individuals. GBS is most frequently found in the lower digestive tract (rectum) and the vagina. It is estimated that approximately 15-25% of pregnant women carry GBS bacteria in their body at any given time, a condition known as colonization. Importantly, carrying GBS does not mean a person is sick or has an infection; it simply means the bacteria are present.

How is GBS Transmitted?

For most people, GBS colonization is asymptomatic and harmless. However, the primary concern regarding GBS arises during pregnancy and childbirth. If a pregnant woman is colonized with GBS, the bacteria can be transmitted to her baby during labor and delivery as the baby passes through the birth canal. This transmission can occur even if the mother has no symptoms. While not all babies born to GBS-positive mothers will contract the infection, there is a risk, and this risk is significantly higher if preventative measures are not taken.

Risks and Complications of GBS in Newborns

When newborns contract GBS during birth, they can develop serious infections, collectively referred to as early-onset GBS disease. These infections can manifest in several ways, including:

These infections can lead to severe illness, long-term disabilities such as developmental delays, hearing loss, or vision problems, and in the most tragic cases, can be fatal. The risk of a baby developing early-onset GBS disease is estimated to be around 1-4 per 1,000 live births for babies born to mothers colonized with GBS who do not receive intrapartum antibiotic prophylaxis (IAP). The risk is considerably higher if risk factors such as preterm birth are present.

Screening and Prevention in Pregnant Women

To mitigate the risks associated with GBS, healthcare providers routinely screen pregnant women for the bacteria. This screening typically involves a simple urine and vaginal swab test performed between 35 and 37 weeks of gestation. The swab samples are sent to a laboratory to detect the presence of GBS.

If a pregnant woman tests positive for GBS, or if she has certain risk factors (such as a previous child with GBS disease, or signs of a urinary tract infection with GBS during pregnancy), she will be recommended to receive intrapartum antibiotic prophylaxis (IAP). This involves administering intravenous (IV) antibiotics, most commonly penicillin or ampicillin, during labor. The antibiotics are given at regular intervals until the baby is born. The purpose of IAP is not to eliminate the GBS from the mother's body, but to significantly reduce the number of bacteria present in the birth canal at the time of delivery, thereby lowering the risk of transmission to the baby.

GBS in Non-Pregnant Individuals

As mentioned, GBS colonization is usually harmless in healthy adults. However, in some cases, GBS can cause infections in non-pregnant individuals, particularly older adults or those with weakened immune systems. These infections can include urinary tract infections (UTIs), skin and soft tissue infections, and in rare instances, more severe conditions like pneumonia or bloodstream infections. For individuals with underlying health conditions, such as diabetes or chronic liver disease, GBS can pose a greater risk of infection.

Diagnosis and Treatment

Diagnosis of GBS in pregnant women is done through the standard screening swabs. For suspected infections in any individual, GBS can be identified through laboratory tests on samples such as blood, urine, or cerebrospinal fluid. Treatment for GBS infections involves antibiotics. The choice of antibiotic depends on the type and severity of the infection, as well as any known allergies or resistance patterns. For pregnant women who are allergic to penicillin, alternative antibiotics are available, but it is crucial to inform healthcare providers of any allergies.

Importance of Communication with Healthcare Providers

Open communication with your healthcare provider is vital throughout your pregnancy. Discuss any concerns you have about GBS, your medical history, and any allergies you may have. Understanding the screening process, the reasons for antibiotic treatment if recommended, and the potential risks and benefits is crucial for making informed decisions about your health and the health of your baby.

Sources

  1. Group B Strep (GBS) | CDCfair-use
  2. Group B Strep (GBS) - NHSfair-use
  3. Group B strep infection - Symptoms and causes - Mayo Clinicfair-use

Missing an answer?

Suggest a question and we'll generate an answer for it.